Protégé Biomedical

About:

Protégé Biomedical is a company with a unique new line of hemostatic products developed to stop bleeding in animals and humans*.

Website: http://www.protegebiomedical.com

Twitter/X: PBiomedical

Description:

Protégé Biomedical is a company with a unique new line of hemostatic products developed to stop bleeding in animals and humans*. Their hemostatic devices use a patent-pending compound of all-natural minerals designed to quickly stop bleeding in minor to severe wounds. Protégé Biomedical will launch their first product, ClotIt, in September. ClotIt is a powder designed to stop bleeding in minor-to-severe animal wounds. *Military, Surgical, and general consumer products are currently in development.

Total Funding Amount:

$2.33M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Eden Prairie, Minnesota, United States

Founded Date:

2011-01-01

Founders:

Michael Wuollett, Susie Wuollett

Number of Employees:

1-10

Last Funding Date:

2019-03-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai